pmc logo image
Logo of westjmedJournal URL: http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=183&action=archive
Journal List > West J Med > v.156(3); Mar 1992

Formats:
West J Med. 1992 March; 156(3): 281–286.
PMCID: PMC1003235
Copyright notice
Blood-brain barrier and new approaches to brain drug delivery.
W. M. Pardridge, R. J. Boado, K. L. Black, and P. A. Cancilla
Department of Medicine, UCLA School of Medicine 90024.
Small right arrow pointing to: See commentary "Rational approaches to breaching the blood-brain barrier." on page 318.
 
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
Morbidity caused by brain dysfunction affects more than 50 million persons in the United States. Although new neuropharmaceuticals have the potential for treating specific brain diseases, they may not effectively enter brain from blood. Safe strategies are needed for drug delivery through the brain capillary wall, which makes up the blood-brain barrier in vivo. Two of these strategies are reviewed, as are related new developments in the molecular and cell biology of the brain capillary endothelium. The production of chimeric peptides represents a physiologic-based strategy for drug delivery. It entails the covalent coupling of the neuropharmaceutical to a brain transport vector, allowing transportation through the blood-brain barrier. Another strategy is biochemical opening of the blood-brain barrier: intracarotid leukotriene infusion is a method for selectively increasing blood-brain barrier permeability in brain tumors without affecting barrier permeability in normal brain tissue.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 281
281
icon of scanned page 282
282
icon of scanned page 283
283
icon of scanned page 284
284
icon of scanned page 285
285
icon of scanned page 286
286
 
Images in this article
Image
Image

Image
on p.283
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Marx J. NGF and Alzheimer's: hopes and fears. Science. 1990 Jan 26;247(4941):408–410. [PubMed]
  • Levi-Montalcini R, Angeletti PU. Nerve growth factor. Physiol Rev. 1968 Jul;48(3):534–569. [PubMed]
  • Harbaugh RE. Nerve growth factor as a potential treatment in Alzheimer's disease. Biomed Pharmacother. 1989;43(7):483–485. [PubMed]
  • Blasberg RG, Patlak C, Fenstermacher JD. Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther. 1975 Oct;195(1):73–83. [PubMed]
  • Aird RB. A study of intrathecal, cerebrospinal fluid-to-brain exchange. Exp Neurol. 1984 Nov;86(2):342–358. [PubMed]
  • Gregoriadis G. The carrier potential of liposomes in biology and medicine (first of two parts). N Engl J Med. 1976 Sep 23;295(13):704–710. [PubMed]
  • Pardridge WM. Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev. 1986 Aug;7(3):314–330. [PubMed]
  • Duffy KR, Pardridge WM. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res. 1987 Sep 8;420(1):32–38. [PubMed]
  • Fishman JB, Rubin JB, Handrahan JV, Connor JR, Fine RE. Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res. 1987;18(2):299–304. [PubMed]
  • Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, Starzyk RM. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4771–4775. [PubMed]
  • Duffy KR, Pardridge WM, Rosenfeld RG. Human blood-brain barrier insulin-like growth factor receptor. Metabolism. 1988 Feb;37(2):136–140. [PubMed]
  • Pardridge WM, Triguero D, Buciak J. Transport of histone through the blood-brain barrier. J Pharmacol Exp Ther. 1989 Dec;251(3):821–826. [PubMed]
  • Kumagai AK, Eisenberg JB, Pardridge WM. Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem. 1987 Nov 5;262(31):15214–15219. [PubMed]
  • Triguero D, Buciak JB, Yang J, Pardridge WM. Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4761–4765. [PubMed]
  • Broadwell RD, Balin BJ, Salcman M. Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc Natl Acad Sci U S A. 1988 Jan;85(2):632–636. [PubMed]
  • Pardridge WM, Triguero D, Buciak J, Yang J. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector. J Pharmacol Exp Ther. 1990 Nov;255(2):893–899. [PubMed]
  • Pardridge WM, Buciak JL, Friden PM. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther. 1991 Oct;259(1):66–70. [PubMed]
  • Pardridge WM, Triguero D, Buciak JL. Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain. Endocrinology. 1990 Feb;126(2):977–984. [PubMed]
  • Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY. Transferrin receptor on endothelium of brain capillaries. Nature. 312(5990):162–163. [PubMed]
  • Juranka PF, Zastawny RL, Ling V. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J. 1989 Dec;3(14):2583–2592. [PubMed]
  • MacDonald PN, Bok D, Ong DE. Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4265–4269. [PubMed]
  • Papandrikopoulou A, Frey A, Gassen HG. Cloning and expression of gamma-glutamyl transpeptidase from isolated porcine brain capillaries. Eur J Biochem. 1989 Aug 15;183(3):693–698. [PubMed]
  • Solhonne B, Gros C, Pollard H, Schwartz JC. Major localization of aminopeptidase M in rat brain microvessels. Neuroscience. 1987 Jul;22(1):225–232. [PubMed]
  • Pardridge WM, Yang J, Eisenberg J. Blood-brain barrier protein phosphorylation and dephosphorylation. J Neurochem. 1985 Oct;45(4):1141–1147. [PubMed]
  • Whelan JP, Eriksson U, Lampson LA. Expression of mouse beta 2-microglobulin in frozen and formaldehyde-fixed central nervous tissues: comparison of tissue behind the blood-brain barrier and tissue in a barrier-free region. J Immunol. 1986 Oct 15;137(8):2561–2566. [PubMed]
  • Barnwell JW, Asch AS, Nachman RL, Yamaya M, Aikawa M, Ingravallo P. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest. 1989 Sep;84(3):765–772. [PubMed]
  • Seulberger H, Lottspeich F, Risau W. The inducible blood--brain barrier specific molecule HT7 is a novel immunoglobulin-like cell surface glycoprotein. EMBO J. 1990 Jul;9(7):2151–2158. [PubMed]
  • Krause D, Vatter B, Dermietzel R. Immunochemical and immunocytochemical characterization of a novel monoclonal antibody recognizing a 140 kDa protein in cerebral pericytes of the rat. Cell Tissue Res. 1988 Jun;252(3):543–555. [PubMed]
  • Sternberger NH, Sternberger LA. Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8169–8173. [PubMed]
  • Weiler-Güttler H, Sommerfeldt M, Papandrikopoulou A, Mischek U, Bonitz D, Frey A, Grupe M, Scheerer J, Gassen HG. Synthesis of apolipoprotein A-1 in pig brain microvascular endothelial cells. J Neurochem. 1990 Feb;54(2):444–450. [PubMed]
  • Pardridge WM, Eisenberg J, Yang J. Human blood-brain barrier insulin receptor. J Neurochem. 1985 Jun;44(6):1771–1778. [PubMed]
  • Weiler-Güttler H, Zinke H, Möckel B, Frey A, Gassen HG. cDNA cloning and sequence analysis of the glucose transporter from porcine blood-brain barrier. Biol Chem Hoppe Seyler. 1989 May;370(5):467–473. [PubMed]
  • Pardridge WM, Boado RJ, Farrell CR. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem. 1990 Oct 15;265(29):18035–18040. [PubMed]
  • Pardridge WM, Eisenberg J, Yang J. Human blood-brain barrier transferrin receptor. Metabolism. 1987 Sep;36(9):892–895. [PubMed]
  • Boado RJ, Pardridge WM. The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier. Biochem Biophys Res Commun. 1990 Jan 15;166(1):174–179. [PubMed]
  • Farrell CL, Pardridge WM. Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5779–5783. [PubMed]
  • Farrell CL, Yang J, Pardridge WM. GLUT-1 glucose transporter is present within apical and basolateral membranes of brain epithelial interfaces and in microvascular endothelia with and without tight junctions. J Histochem Cytochem. 1992 Feb;40(2):193–199. [PubMed]
  • Fenstermacher JD, Cowles AL. Theoretic limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep. 1977 Jul;61(4):519–526. [PubMed]
  • Groothuis DR, Fischer JM, Lapin G, Bigner DD, Vick NA. Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol. 1982 Mar;41(2):164–185. [PubMed]
  • Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4420–4423. [PubMed]
  • Neuwelt EA, Barnett PA, McCormick CI, Frenkel EP, Minna JD. Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. Neurosurgery. 1985 Sep;17(3):419–423. [PubMed]
  • Neuwelt EA, Hill SA, Frenkel EP. Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurgery. 1984 Sep;15(3):362–366. [PubMed]
  • Tomiwa K, Hazama F, Mikawa H. Neurotoxicity of vincristine after the osmotic opening of the blood-brain barrier. Neuropathol Appl Neurobiol. 1983 Sep–Oct;9(5):345–354. [PubMed]
  • Neuwelt EA, Rapoport SI. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc. 1984 Feb;43(2):214–219. [PubMed]
  • Nakagawa H, Groothuis D, Blasberg RG. The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas. Neurology. 1984 Dec;34(12):1571–1581. [PubMed]
  • Black KL, King WA, Ikezaki K. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4. J Neurosurg. 1990 Jun;72(6):912–916. [PubMed]
  • Aharony D, Dobson P. Discriminative effect of gamma-glutamyl transpeptidase inhibitors on metabolism of leukotriene C4 in peritoneal cells. Life Sci. 1984 Nov 19;35(21):2135–2142. [PubMed]
  • DeBault LE. gamma-Glutamyltranspeptidase induction mediated by glial foot process-to endothelium contact in co-culture. Brain Res. 1981 Sep 14;220(2):432–435. [PubMed]
  • Soter NA, Lewis RA, Corey EJ, Austen KF. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol. 1983 Feb;80(2):115–119. [PubMed]
  • Black KL, Hoff JT, McGillicuddy JE, Gebarski SS. Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans. Ann Neurol. 1986 Jun;19(6):592–595. [PubMed]
  • Baba T, Black KL, Ikezaki K, Chen KN, Becker DP. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J Cereb Blood Flow Metab. 1991 Jul;11(4):638–643. [PubMed]
  • Cancilla PA, Frommes SP, Kahn LE, DeBault LE. Regeneration of cerebral microvessels: a morphologic and histochemical study after local freeze-injury. Lab Invest. 1979 Jan;40(1):74–82. [PubMed]
  • Cancilla PA, DeBault LE. Freeze injury and repair of cerebral microvessels. Adv Exp Med Biol. 1980;131:257–269. [PubMed]
  • Beck DW, Hart MN, Cancilla PA. The role of the macrophage in microvascular regeneration following brain injury. J Neuropathol Exp Neurol. 1983 Nov;42(6):601–614. [PubMed]
  • Maxwell K, Berliner JA, Cancilla PA. Induction of gamma-glutamyl transpeptidase in cultured cerebral endothelial cells by a product released by astrocytes. Brain Res. 1987 May 5;410(2):309–314. [PubMed]
  • Estrada C, Bready JV, Berliner JA, Pardridge WM, Cancilla PA. Astrocyte growth stimulation by a soluble factor produced by cerebral endothelial cells in vitro. J Neuropathol Exp Neurol. 1990 Nov;49(6):539–549. [PubMed]
  • Minakawa T, Bready J, Berliner J, Fisher M, Cancilla PA. In vitro interaction of astrocytes and pericytes with capillary-like structures of brain microvessel endothelium. Lab Invest. 1991 Jul;65(1):32–40. [PubMed]
  • Pardridge WM, Oldendorf WH, Cancilla P, Frank HJ. Blood-brain barrier: interface between internal medicine and the brain. Ann Intern Med. 1986 Jul;105(1):82–95. [PubMed]
  • Beck DW, Vinters HV, Hart MN, Cancilla PA. Glial cells influence polarity of the blood-brain barrier. J Neuropathol Exp Neurol. 1984 May;43(3):219–224. [PubMed]
  • Stewart PA, Wiley MJ. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail--chick transplantation chimeras. Dev Biol. 1981 May;84(1):183–192. [PubMed]
  • Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 325(6101):253–257. [PubMed]
  • Tao-Cheng JH, Brightman MW. Development of membrane interactions between brain endothelial cells and astrocytes in vitro. Int J Dev Neurosci. 1988;6(1):25–37. [PubMed]
Articles from The Western Journal of Medicine are provided here courtesy of
BMJ Group

PubMed articles by these authors